COLBIE ODEN: Open Payments
NPI 1790358208 · COLUMBIA, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,169 in 91 payments from 18 companies in 2025. Trend: 2023 $405 · 2024 $385 · 2025 $2,169
Food & beverage: $2,169
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 12 | $425 |
| PFIZER INC. | 12 | $324 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $224 |
| Novo Nordisk Inc | 12 | $213 |
| Axsome Therapeutics, Inc. | 5 | $193 |
| Lilly USA, LLC | 11 | $171 |
| ABBVIE INC. | 10 | $165 |
| Exact Sciences Corporation | 3 | $78 |
| Astellas Pharma US Inc | 4 | $65 |
| GlaxoSmithKline, LLC. | 3 | $54 |
Products named: AIRSUPRA, NURTEC ODT, Kerendia, Auvelity, Ozempic, JARDIANCE, BREZTRI, MOUNJARO.
Industry payments across MD — which companies pay providers there.
